One pill to stop breast pain after pregnancy loss: new study shows promise
NCT ID NCT06029673
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a single dose of cabergoline can prevent breast pain, engorgement, and milk leakage in people who had an abortion or pregnancy loss between 16 and 20 weeks. 69 participants were randomly assigned to receive cabergoline or a placebo. The goal was to see if the drug could reduce physical and emotional distress from breast symptoms.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LACTATION SUPPRESSED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Planned Parenthood - San Jose Central Health Center
San Jose, California, 95126, United States
-
Stanford University
Stanford, California, 94305, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.